Arkema Completes Its 40% Increase in Global Pebax® Elastomers Production Capacity
01 Febrero 2024 - 1:00AM
Business Wire
To support its customers’ strong growth, in particular in the
sports and consumer goods markets, Arkema has increased its global
manufacturing capacity for Pebax® elastomers by 40% at its
Serquigny plant in France.
Regulatory News:
Arkema (Paris:AKE) has successfully started its new Pebax®
elastomer unit at the Serquigny plant in France. This new unit,
designed with the latest advancements in industrial processes, can
produce both the bio-circular Pebax® Rnew® and classical Pebax®
elastomer ranges. These advanced materials are used extensively in
sports equipment such as running shoes, soccer shoes and ski boots,
but also in electronic devices, and other specialty markets such as
antistatic additives and medical devices.
‘‘We are excited to start the production of this expansion in
our Pebax® elastomers capacity” said Erwoan Pezron, Senior
Vice-President of Arkema’s High Performance Polymers Business Line.
“This represents a great opportunity for us to meet growing demand
in existing and new applications while simultaneously improving our
processes as water consumption at the site will be reduced by
approximately 25%.”
Building on its unique set of expertise in materials science,
Arkema offers a portfolio of first-class technologies to address
ever-growing demand for new and sustainable materials. With the
ambition to become in 2024 a pure player in Specialty Materials,
the Group is structured into 3 complementary, resilient and highly
innovative segments dedicated to Specialty Materials - Adhesive
Solutions, Advanced Materials, and Coating Solutions - accounting
for some 91% of Group sales in 2022, and a well-positioned and
competitive Intermediates segment. Arkema offers cutting-edge
technological solutions to meet the challenges of, among other
things, new energies, access to water, recycling, urbanization and
mobility, and fosters a permanent dialogue with all its
stakeholders. The Group reported sales of around € 11.5 billion in
2022, and operates in some 55 countries with 21,100 employees
worldwide.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131156459/en/
Investor relations contacts: Béatrice Zilm +33 (0)1 49 00 75 58
beatrice.zilm@arkema.com Peter Farren +33 (0)1 49 00 73 12
peter.farren@arkema.com Mathieu Briatta +33 (0)1 49 00 72 07
mathieu.briatta@arkema.com Alexis Noël +33 (0)1 49 00 74 37
alexis.noel@arkema.com
Media contact: Anne Plaisance +33 (0)6 81 87 48 77
anne.plaisance@arkema.com
Alikem (TSX:AKE)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Alikem (TSX:AKE)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024